SMOOTH MUSCLE CELLS (SMCS) in vascular and other tissues reversibly change their tone in response to acute variations in oxygen tension, and this results in important physiological and pathophysiological responses of the organ or system. The best studied example includes the changes in blood vessel diameter in response to decreases in oxygen tension (hypoxia). Thus, in response to tissue hypoxia, systemic peripheral arteries normally dilate, thereby increasing oxygen delivery into the tissue. Conversely, in the lung, hypoxia constricts the pulmonary arteries-a response called hypoxic pulmonary vasoconstriction (HPV), which can have either beneficial effects, by reducing and diverting blood flow from poor ventilated regions in the lung and thus optimizing ventilation-perfusion matching and gas exchange, or detrimental effects by increasing pulmonary vascular resistance, resulting in pulmonary hypertension at high altitude or during lung disease (3). In addition, the SMCs in other systems also respond to changes in oxygen tension. For example in the lung, the airways relax in response to hypoxia (7), which also may have a role in ventilationperfusion matching by facilitating ventilation of hypoxic alveoli.
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Despite previous research efforts, the mechanisms of hypoxia-induced changes in SMC tone are still incompletely understood. Several proposed mechanisms and controversy in the field are summarized in a recent excellent review (8) . A first step in the recognition of the hypoxia stimulus is sensing the oxygen level in the tissue or bloodstream; there appears to be consensus in that the cell that senses the oxygen level is the SMC itself. However, several questions remain unanswered: What are the oxygen-sensing molecules? Where are the sensors located in the cell? How do these sensors sense the oxygen level change?
Recently, the group led by Kenneth Olson at Indiana University School of Medicine has proposed a revolutionary hypothesis that, if confirmed, may help to find the answers to the above questions. This hypothesis suggests that a new gasotransmitter, hydrogen sulfide (H 2 S) (9) may be an early mediator of the contractile responses of vascular SMCs to hypoxia (1, 4) . The accumulated evidence that support this proposition have been summarized in recent reviews (5, 9) and include the following observations: 1) H 2 S is synthesized by cells in the blood vessels; its synthesis is stimulated during hypoxia, and the H 2 S concentration is affected by oxygen level via multiple mechanisms, including oxygen-regulated enzymatic production in the cytosol and oxygen-dependent consumption in mitochondria; 2) the vascular responses to hypoxia and H 2 S of a given blood vessel, either systemic or pulmonary (including the blood vessels in gills) are virtually identical in many vertebrate species, from cows to lamprey, irrespective of whether the effect is relaxation, constriction, or a complex response, 3) the responses to hypoxia and H 2 S are competitive in that maximal stimulation with one prevents a response to the other; 4) the sulfur donor, cysteine, augments the response to hypoxia; and 5) inhibitors of H 2 S biosynthesis also inhibit the responses to hypoxia. Together, the accumulated evidence strongly suggests that H 2 S is an early mediator of the hypoxic responses of blood vessels, whereas the oxygen sensor must be located in one or multiple molecules responsible for the regulation of H 2 S concentration in the cells of the blood vessels.
In this issue, Skovgaard and Olson (6) now report a detailed comparative study of the vascular effects of hypoxia and H 2 S in trout gills that provides further evidence that H 2 S is a mediator of the hypoxic response of respiratory vasculature. They found that both hypoxia and H 2 S trigger vasoconstriction in the gills, both fast and transient. The responses triggered by hypoxia and H 2 S had similar magnitudes and kinetics, were not additive, and were mutually exclusive in that prestimulation with one stimulus inhibited the effect of the other stimulus. The hypoxia-induced vasoconstrictor was blocked by inhibitors of H 2 S synthesis. These results confirm the hypothesis that H 2 S is an early mediator of the vascular response to hypoxia. In addition, the response to H 2 S, as well as to hypoxia, was abolished by inhibition of the mitochondrial electron transport systems. Furthermore, the responses to hypoxia and H 2 S were inhibited by the antioxidant and superoxide scavenger glutathione, whereas hydrogen peroxide (H 2 O 2 ) triggered similar contractile responses in nonstimulated gills. These last two findings are very important since it allows the authors to propose that H 2 S mediates hypoxic vasoconstriction in trout gills through the production of reactive oxygen species (ROS) by the mitochondria and H 2 O 2 generation. This important conclusion links H 2 S to the well-supported role of ROS and H 2 O 2 in the mediation of the vascular responses to hypoxia (3, 8) .
In conclusion, the new findings presented by Skovgaard and Olson (6) in this issue support a new hypothesis that proposes that endogenous H 2 S is an early mediator of the responses of vascular SMCs to hypoxia that is upstream of mitochondrial ROS production and H 2 O 2 generation. Finally, it is possible that in other SMCs that respond to hypoxia, H 2 S may be as well the early mediator of the responses to hypoxia. For example, airway SMCs are relaxed by both hypoxia (7) and H 2 S (2), and it will be interesting to learn whether both responses have similar kinetics and pharmacological properties, and whether they are mutually exclusive. Thus, we can look forward to other studies that will test this novel hypothesis in vascular and other SMC types, as well as in other cells and tissues that respond to hypoxia.
